AD2000: design and conclusions

Lancet. 2004 Oct;364(9441):1213-4; author reply 1216-7. doi: 10.1016/S0140-6736(04)17127-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Cholinesterase Inhibitors / therapeutic use*
  • Donepezil
  • Humans
  • Indans / therapeutic use*
  • Nootropic Agents / therapeutic use*
  • Piperidines / therapeutic use*
  • Quality of Life
  • Randomized Controlled Trials as Topic
  • Research Design

Substances

  • Cholinesterase Inhibitors
  • Indans
  • Nootropic Agents
  • Piperidines
  • Donepezil